Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.

IF 4.4 2区医学 Q1 PHARMACOLOGY & PHARMACY

Frontiers in Pharmacology Pub Date : 2024-12-19 eCollection Date: 2024-01-01 DOI:10.3389/fphar.2024.1528449

Yongmei Feng, Stefan Grotegut, Predrag Jovanovic, Valentina Gandin, Steven H Olson, Rabi Murad, Anne Beall, Sharon Colayco, Paul De-Jesus, Sumit Chanda, Brian P English, Robert H Singer, Michael Jackson, Ivan Topisirovic, Ze'ev A Ronai

引用次数: 0

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.1029093.].

查看原文本刊更多论文

[This corrects the article DOI: 10.3389/fphar.2022.1029093.].

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Pharmacology PHARMACOLOGY & PHARMACY-

CiteScore

7.80

自引率

8.90%

发文量

5163

审稿时长

14 weeks

期刊介绍： Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.